Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals:...

Area of Science:

• Health Services Research
• Health Economics
• Quality Improvement

Background:

• The US Hospital Value-Based Purchasing (HVBP) program, a Medicare initiative, aims to improve healthcare quality by incentivizing hospitals.
• Understanding the impact of such pay-for-performance programs on patient mortality is crucial for healthcare policy and practice.

Purpose of the Study:

• To evaluate the effect of the HVBP program on 30-day mortality rates for acute myocardial infarction, heart failure, and pneumonia.
• To determine if the HVBP program demonstrated particular benefits for hospitals with lower baseline performance.

Main Methods:

• An observational study analyzed data from 4,267 US acute care hospitals between 2008 and 2013.
• Patient-level data for over 2.4 million admissions were used to assess 30-day risk-adjusted mortality.
• Linear spline analysis examined the association between HVBP participation and mortality trends, comparing incentivized conditions to non-incentivized ones.

Main Results:

• Mortality rates for incentivized conditions showed similar modest declines in both HVBP-participating and non-participating hospitals.
• The difference in mortality trends between participating and non-participating hospitals was not statistically significant.
• No subgroup analysis, including hospitals with poor baseline performance, indicated that HVBP was associated with improved outcomes.

Conclusions:

• Current evidence does not support the effectiveness of the HVBP program in reducing 30-day mortality for the studied conditions.
• Policymakers considering similar pay-for-performance models should explore alternative strategies to enhance patient outcomes.